Lima Memorial Health System Logo
Approximate ER WAIT TIME
5

Health Library

Transient tachypnea - newborn
Site Map

Transient tachypnea - newborn

TTN; Wet lungs - newborns; Retained fetal lung fluid; Transient RDS; Prolonged transition; Neonatal - transient tachypnea

Transient tachypnea of the newborn (TTN) is a breathing disorder seen shortly after delivery, most often in early term or late preterm babies.

  • Transient means it is short-lived (most often less than 48 hours).
  • Tachypnea means rapid breathing (faster than most newborns, who normally breathe 40 to 60 times per minute).

I Would Like to Learn About:

Causes

As the baby grows in the womb (uterus), the lungs make a special fluid. This fluid fills the baby's lungs and helps them grow. When the baby is born at term, hormones released during labor tell the lungs to stop making this special fluid. The baby's lungs start removing or reabsorbing it.

The first few breaths a baby takes after delivery fill the lungs with air and help to clear most of the remaining lung fluid.

Leftover fluid in the lungs causes the baby to breathe rapidly. It is harder for the small air sacs of the lungs to stay open.

TTN is more likely to occur in babies who are:

  • Born before 38 completed weeks gestation (preterm, or early term)
  • Delivered by C-section, especially if labor has not already started
  • Born to a mother with diabetes or asthma
  • Twins

Symptoms

Newborns with TTN have breathing problems soon after birth, usually starting within 1 to 2 hours.

Symptoms include:

  • Bluish skin color (cyanosis)
  • Rapid breathing, which may occur with noises such as grunting
  • Flaring nostrils or movements between the ribs or breastbone known as retractions

Exams and Tests

The mother's pregnancy and labor history are important to make the diagnosis.

Tests performed on the baby may include:

  • Blood count and blood culture to rule out infection
  • Chest x-ray to rule out other causes of breathing problems
  • Blood gas to check levels of carbon dioxide and oxygen
  • Continuous monitoring of the baby's oxygen levels, breathing, and heart rate

The diagnosis of TTN is most often made after the baby is monitored for 2 or 3 days. If the condition goes away in that time, it is considered to be transient.

Treatment

Your baby will be given oxygen, and sometimes CPAP (continuous positive airway pressure) as well, to keep the blood oxygen level and breathing rate stable. Your baby will often need the most support within a few hours after birth and will usually begin to improve after that. Most infants with TTN improve in less than 24 to 48 hours, but some will need help for a few days.

Very rapid breathing usually means a baby is unable to eat. Fluids and nutrients will be given through a vein until your baby improves. Your baby may also receive antibiotics if there is concern for infection. Sometimes, babies with TTN will need help with breathing or feeding for a week or more, usually if they are premature.

Outlook (Prognosis)

The condition most often goes away within 48 to 72 hours after delivery. In most cases, babies who have had TTN have no further problems from the condition. They will not need special care or follow-up other than their routine checkups. However, there is some evidence that babies with TTN may be at a higher risk for wheezing problems later in infancy.

Related Information

Rapid shallow breathing
C-section
Diabetes

References

Ahlfeld SK. Respiratory tract disorders. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 122.

Crowley MA. Spectrum of neonatal respiratory disorders. In: Martin RJ, Fanaroff AA, eds. Fanaroff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 67.

BACK TO TOP

Review Date: 12/31/2023  

Reviewed By: Mary J. Terrell, MD, IBCLC, Neonatologist, Cape Fear Valley Medical Center, Fayetteville, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.